on October 25, 2007
Published online before print October 25, 2007, doi: 10.1161/ATVBAHA.107.153080
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 13, 2006
Accepted on September 6, 2007
IL-6 Deficiency Protects Against Angiotensin II–Induced Endothelial Dysfunction and Hypertrophy
Laura I. Schrader ;
From the Departments of Internal Medicine and Pharmacology, Cardiovascular Center, The University of Iowa Carver College of Medicine, Iowa City.
* To whom correspondence should be addressed. E-mail: sean-didion{at}uiowa.edu.
Objective—The goal of this study was to test the hypothesis that IL-6 mediates the increases in superoxide, vascular hypertrophy, and endothelial dysfunction in response to angiotensin II (Ang II).
Methods and Results—Responses of carotid arteries from control and IL-6–deficient mice were examined after acute (22-hour) incubation with Ang II (10 nmol/L) or chronic infusion of Ang II (1.4 mg/kg/d for 14 days). The hypertrophic response and endothelial dysfunction produced by Ang II infusion was markedly less in carotid arteries from IL-6–deficient mice than that in control mice. IL-6 deficiency protected against endothelial dysfunction in response to acute (local) Ang II treatment (eg, 100 µmol/L acetylcholine produced 100±4 and 98±4% relaxation in vehicle-treated and 51±4 and 99±4% relaxation in Ang II–treated, control, and IL-6–deficient vessels, respectively). Endothelial dysfunction could be reproduced in vessels from IL-6–deficient mice with combined Ang II plus IL-6 (0.1 nmol/L) treatment. Increases in vascular superoxide and IL-6, as well as reductions in endothelial nitric oxide synthase mRNA expression, produced by Ang II were absent in IL-6–deficient mice.
Conclusions—These data demonstrate that IL-6 produced locally within the vessel wall is essential for Ang II–induced increases in superoxide, endothelial dysfunction, and vascular hypertrophy.
Key words: genetically-altered mice • inflammation • oxidative stress • endothelium-dependent responses
This article has been cited by other articles:
 |
|
 |
|
  S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, Y. Chu, and F. M. Faraci Endogenous Interleukin-10 Inhibits Angiotensin II-Induced Vascular Dysfunction Hypertension, September 1, 2009; 54(3): 619 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Welch Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction Hypertension, July 1, 2008; 52(1): 51 - 56. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, T. Hibuse, H. Nishizawa, M. Nishida, A. Hiuge, A. Kurata, S. Kihara, et al. Adiponectin Protects Against Angiotensin II-Induced Cardiac Fibrosis Through Activation of PPAR-{alpha} Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Didion Chlamydophila pneumoniae and Endothelial Activation: The Smoke That Precedes the Fire of Atherosclerosis? Circ. Res., April 25, 2008; 102(8): 861 - 863. [Full Text] [PDF]
|
|
|
|
|
|
S. Chrissobolis, S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, S. Dayal, S. R. Lentz, and F. M. Faraci Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II-Induced Vascular Dysfunction Hypertension, April 1, 2008; 51(4): 872 - 877. [Abstract] [Full Text] [PDF]
|
|